Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial

WEST LAFAYETTE, Ind., May 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research...

Related Keywords

United States ,Seongnam ,Kyonggi Do ,South Korea ,Morrisville ,North Carolina ,Texas ,America ,Boulder Bio ,Plato Biopharma ,Robert Leasure Jr ,Orient Bioresource Center Inc ,Plato Biopharma Inc ,Bolder Biopath Inc ,Histotox Labs Inc ,Synexa Life Sciences ,Orient Bio Inc ,Holding Corp ,Nasdaq ,Accreditation Of Laboratory Animal Care ,Bioreliance Corporation ,Inotiv Inc ,Robinson Services Inc ,Laboratory Systems Holdings ,Gateway Pharmacology Laboratories ,Association For Assessment ,Histotox Labs ,Robinson Services ,Integrated Laboratory Systems Holdings ,Orient Bioresource Center ,Gateway Pharmacology ,Laboratory Animal Care ,Orient Bio ,Incremental Term Loans ,Fernanda Beraldi ,General Counsel ,Corporate Secretary ,Chief Technology Officer ,Chief Executive Officer ,Fort Collins ,North America ,Nasdaq Notv ,Inotiv ,Nc ,Financial ,Investor ,Investor Relations ,Epro Services ,Pro ,Financial Results ,Drug Discovery ,Drug Development ,Envigo ,